Breaking News

Tweet TWEET

Solazyme and AkzoNobel Enter Agreement Spanning Surfactants and Coatings Markets

  Solazyme and AkzoNobel Enter Agreement Spanning Surfactants and Coatings
  Markets

Agreement targets joint product development and supply of tailored algal oils
                                  in Brazil

Business Wire

SOUTH SAN FRANCISCO, Calif. -- May 8, 2013

Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and
AkzoNobel, a leading global paints and coatings company and a major producer
of specialty chemicals, announced today that they have entered into an
agreement targeting the development of advanced tailored oils and commercial
sales for near-term product supply.

Tailored oils can enhance or replace petroleum-derived chemicals, and improve
upon the performance of plant oils and animal fats. The Solazyme and AkzoNobel
agreement is rooted in a shared commitment to sustainability and
high-performance products derived from triglyceride oils.

“AkzoNobel’s leadership in specialty chemicals and sustainability makes them a
natural partner for us to work with,” said Jean-Marc Rotsaert, Chief Operating
Officer, Solazyme. “Akzo’s significant product sales and growth strategy in
the Americas also overlaps well with our manufacturing footprint.”

Commercial supply of multi-thousand ton quantities of highly sustainable algal
oil is expected to originate from the Solazyme Bunge Renewable Oils Joint
Venture oil manufacturing plant in Brazil. Sales of product are anticipated to
commence in 2014, with pricing to be competitive and based upon Solazyme’s
cost of manufacturing.

“We think the tailored triglycerides developed by Solazyme can offer valuable
new technology for our Surface Chemistry and Decorative Paints businesses, and
we are excited about our partnership with such an innovative, promising new
business,” said Graeme Armstrong, Corporate Director for Research, Development
and Innovation, AkzoNobel. Added Peter Nieuwenhuizen, Director Future-proof
Supply Chains, “We look forward to a multi-faceted alliance with Solazyme,
including supply in the Americas region, and joint research and development to
drive new functionality alongside improved sustainability.”

Product development efforts are anticipated to begin in the second half of
2013, and are focused on a number of AkzoNobel’s end market applications,
specifically surfactants and paints and coatings.

About Solazyme:

Solazyme, Inc. is a renewable oil and bioproducts company that transforms a
range of low-cost plant-based sugars into high-value tailored oils.
Headquartered in South San Francisco, Solazyme’s renewable products can
replace or enhance oils derived from the world’s three existing sources –
petroleum, plants and animal fats. Initially, Solazyme is focused on
commercializing its products into three target markets: (1) fuels and
chemicals, (2) nutrition and (3) skin and personal care. Solazyme's oils and
fuels provide compelling solutions to increasingly complex issues of fuel
scarcity, energy security and environmental impact while fitting into the
pre-existing multi-trillion dollar fuel infrastructure. For more information,
please visit our website: http://www.solazyme.com

Solazyme®, the Solazyme logo and other trademarks or service names are the
trademarks of Solazyme, Inc.

About AkzoNobel:

AkzoNobel is a leading global paints and coatings company and a major producer
of specialty chemicals. AkzoNobel supply industries and consumers worldwide
with innovative products and are passionate about developing sustainable
answers for our customers. The AkzoNobel portfolio includes well-known brands
such as Dulux, Sikkens, International and Eka. Headquartered in Amsterdam, the
Netherlands, AkzoNobel are consistently ranked as one of the leaders in the
area of sustainability. With operations in more than 80 countries, AkzoNobel’s
50,000 people around the world are committed to excellence and delivering
Tomorrow’s Answers Today™.

This press release contains certain forward-looking statements about Solazyme,
including statements that involve risks and uncertainties concerning:
agreement on the oils to be developed; the potential uses of such oils; the
ability to launch successful products from such development; the speed of any
such development; market demand for such products; the impact of new product
introduction on long-term competitiveness and pricing; agreement on definitive
supply terms; and Solazyme's ability to maintain its relationships with its
partners and customers. When used in this press release, the words "will",
"expects", "intends" and other similar expressions and any other statements
that are not historical facts are intended to identify those assertions as
forward-looking statements. Any such statement may be influenced by a variety
of factors, many of which are beyond the control of Solazyme, that could cause
actual outcomes and results to be materially different from those projected,
described, expressed or implied in this press release due to a number of risks
and uncertainties. Potential risks and uncertainties include, among others:
Solazyme's limited operating history; its limited history in commercializing
products; implementation risk in deploying new technologies; market acceptance
of its products; and its ability to enter into and maintain strategic
collaborations. Accordingly, no assurances can be given that any of the events
anticipated by the forward-looking statements will transpire or occur, or if
any of them do so, what impact they will have on the results of operations or
financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the
Securities and Exchange Commission, including its Annual Report on Form 10-K,
as updated from time to time, for a discussion of these and other risks. You
are cautioned not to place undue reliance on forward-looking statements, which
speak only as of the date of this press release. Solazyme is not under any
duty to update any of the information in this press release.

Contact:

Solazyme, Inc.
Genet Garamendi, 650-963-5228
VP of Communications
Press@solazyme.com
 
Press spacebar to pause and continue. Press esc to stop.